BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27490206)

  • 1. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers.
    López-Mejías R; Castañeda S; González-Juanatey C; Corrales A; Ferraz-Amaro I; Genre F; Remuzgo-Martínez S; Rodriguez-Rodriguez L; Blanco R; Llorca J; Martín J; González-Gay MA
    Autoimmun Rev; 2016 Nov; 15(11):1013-1030. PubMed ID: 27490206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic markers of cardiovascular disease in rheumatoid arthritis.
    Rodríguez-Rodríguez L; López-Mejías R; García-Bermúdez M; González-Juanatey C; González-Gay MA; Martín J
    Mediators Inflamm; 2012; 2012():574817. PubMed ID: 22927710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis.
    García-Bermúdez M; González-Juanatey C; Rodríguez-Rodríguez L; Miranda-Filloy JA; Perez-Esteban S; Vazquez-Rodriguez TR; Castañeda S; Balsa A; Fernández-Gutierrez B; Llorca J; González-Alvaro I; Martín J; González-Gay MA
    Clin Exp Rheumatol; 2011; 29(4):681-8. PubMed ID: 21906432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; Gonzalez-Juanatey C; Lopez-Diaz MJ; Piñeiro A; Garcia-Porrua C; Miranda-Filloy JA; Ollier WE; Martin J; Llorca J
    Arthritis Rheum; 2007 Feb; 57(1):125-32. PubMed ID: 17266100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis.
    Gonzalez-Gay MA; Llorca J; Palomino-Morales R; Gomez-Acebo I; Gonzalez-Juanatey C; Martin J
    Clin Exp Rheumatol; 2009; 27(1):116-9. PubMed ID: 19327239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis: genetic variants as biomarkers of cardiovascular disease.
    Rodriguez-Rodriguez L; López-Mejias R; Fernández-Gutiérrez B; Balsa A; González-Gay MA; Martín J
    Curr Pharm Des; 2015; 21(2):182-201. PubMed ID: 25163740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in patients with rheumatoid arthritis.
    Liao KP
    Trends Cardiovasc Med; 2017 Feb; 27(2):136-140. PubMed ID: 27612551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis.
    Rodríguez-Rodríguez L; González-Juanatey C; Palomino-Morales R; Vázquez-Rodríguez TR; Miranda-Filloy JA; Fernández-Gutiérrez B; Llorca J; Martin J; González-Gay MA
    Atherosclerosis; 2011 May; 216(1):125-30. PubMed ID: 21420089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning-Based Tissue Characterization.
    Khanna NN; Jamthikar AD; Gupta D; Piga M; Saba L; Carcassi C; Giannopoulos AA; Nicolaides A; Laird JR; Suri HS; Mavrogeni S; Protogerou AD; Sfikakis P; Kitas GD; Suri JS
    Curr Atheroscler Rep; 2019 Jan; 21(2):7. PubMed ID: 30684090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents.
    Carbone F; Bonaventura A; Liberale L; Paolino S; Torre F; Dallegri F; Montecucco F; Cutolo M
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):1-14. PubMed ID: 30259381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictors of cardiovascular events in a cohort of patients with rheumatoid arthritis.
    Castro AM; Carmona-Fernandes D; Rodrigues AM; Pedro LM; Santos MJ; Canhão H; Fonseca JE
    Acta Reumatol Port; 2016; 41(3):213-219. PubMed ID: 27682808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis.
    Garcia-Bermudez M; González-Juanatey C; Lopez-Mejias R; Rodriguez-Rodriguez L; Pérez-Esteban S; Castañeda S; Urcelay E; Miranda-Filloy JA; Gómez-Vaquero C; Fernández-Gutierrez B; Balsa A; González-Alvaro I; Blanco R; Llorca J; Martín J; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2012; 30(1):51-7. PubMed ID: 22272574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DRB1 shared epitope alleles in patients with rheumatoid arthritis: relation to autoantibodies and disease severity in a south Indian population.
    Konda Mohan V; Ganesan N; Gopalakrishnan R; Venkatesan V
    Int J Rheum Dis; 2017 Oct; 20(10):1492-1498. PubMed ID: 27943654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis.
    del Rincón I; Freeman GL; Haas RW; O'Leary DH; Escalante A
    Arthritis Rheum; 2005 Nov; 52(11):3413-23. PubMed ID: 16255018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis.
    López-Mejías R; Corrales A; Genre F; Hernández JL; Ochoa R; Blanco R; González-Juanatey C; Martín J; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2013; 31(5):761-6. PubMed ID: 23899926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study.
    Rodríguez-Rodríguez L; González-Juanatey C; García-Bermúdez M; Vázquez-Rodríguez TR; Miranda-Filloy JA; Fernández-Gutiérrez B; Llorca J; Martin J; González-Gay MA
    Arthritis Res Ther; 2011 Aug; 13(4):R133. PubMed ID: 21846359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis.
    García-Bermúdez M; López-Mejías R; González-Juanatey C; Castañeda S; Miranda-Filloy JA; Blanco R; Fernández-Gutiérrez B; Balsa A; González-Álvaro I; Gómez-Vaquero C; Llorca J; Martín J; González-Gay MA
    Scand J Rheumatol; 2012 Oct; 41(5):350-3. PubMed ID: 22657383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis.
    Carroll L; Frazer IH; Turner M; Marwick TH; Thomas R
    Arthritis Res Ther; 2007; 9(2):R39. PubMed ID: 17425804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies.
    Ambrosino P; Lupoli R; Di Minno A; Tasso M; Peluso R; Di Minno MN
    Thromb Haemost; 2015 May; 113(5):916-30. PubMed ID: 25716931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients.
    Rodríguez-Rodríguez L; García-Bermúdez M; González-Juanatey C; Vazquez-Rodriguez TR; Miranda-Filloy JA; Fernández-Gutierrez B; Llorca J; Martín J; González-Gay MA
    Tissue Antigens; 2011 Apr; 77(4):291-7. PubMed ID: 21388351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.